Engineered therapeutic antibodies with improved effector functions
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-09-10
著者
-
Hanai Nobuo
Biowa Inc.
-
Shitara Kenya
協和醗酵工業東京研究所
-
Shitara Kenya
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Shitara Kenya
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Niwa Rinpei
Department Of Antibody Research Pharmaceutical Research Center Kyowa Hakko Kogyo Co. Ltd.
-
Satoh Mitsuo
Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd
-
NIWA Rinpei
Antibody Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd
-
KUBOTA Tsuguo
Antibody Research Laboratories, Kyowa Hakko Kirin Co., Ltd
-
AKINAGA Shiro
Department of Clinical Development, Kyowa Hakko Kirin Co., Ltd
-
HANAI Nobuo
Department of Development Division, Kyowa Hakko Kirin Co., Ltd
-
Akinaga Shiro
Department Of Clinical Development Kyowa Hakko Kirin Co. Ltd
-
Niwa Rinpei
Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd
-
Hanai Nobuo
Department Of Development Division Kyowa Hakko Kirin Co. Ltd
-
Shitara Kenya
Department Of Strategic Product Planning Kyowa Hakko Kirin Co. Ltd
-
Kubota Tsuguo
Antibody Research Laboratories Kyowa Hakko Kirin Co. Ltd
-
Akinaga Shiro
Department of Chemistry, School of Science and Engineering, Waseda University
関連論文
- Mouse-Human Chimeric Anti-Tn IgG1 Induced Anti-tumor Activity against Jurkat Cells in Vitro and in Vivo(Pharmacology)
- 糖鎖に関わる応用研究の潮流と展開 : 抗体医薬
- Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides
- Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene-Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region
- Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
- Engineered therapeutic antibodies with improved effector functions
- Photolyses of (2-substituted 2-(alkoxycarbonyl)propyl)cobaloximes.